{"id":"NCT05780268","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","briefTitle":"LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)","officialTitle":"A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With COVID-19 (Trial H1: LY3819253 (LY-CoV555))","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-08-05","primaryCompletion":"2021-02-01","completion":"2021-02-01","firstPosted":"2023-03-22","resultsPosted":"2023-10-10","lastUpdate":"2023-12-27"},"enrollment":314,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["COVID-19"],"interventions":[{"type":"BIOLOGICAL","name":"LY3819253","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Remdesivir","otherNames":["Veklury"]}],"arms":[{"label":"LY3819253 plus SOC","type":"EXPERIMENTAL"},{"label":"Placebo plus SOC","type":"PLACEBO_COMPARATOR"}],"summary":"This study looks at the safety and effectiveness of LY3819253 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either LY3819253 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H1.","primaryOutcome":{"measure":"Number of Participants With Sustained Recovery","timeFrame":"Through Day 90","effectByArm":[{"arm":"LY3819253 Plus SOC","deltaMin":144,"sd":null},{"arm":"Placebo Plus SOC","deltaMin":136,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":9},"locations":{"siteCount":57,"countries":["United States","Denmark","Singapore","Spain"]},"refs":{"pmids":["33356051"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":163},"commonTop":["Dyspnoea","Fatigue","Hypotension","Mental status changes","Respiratory failure"]}}